Overview |
bs-10982R-APC-Cy5 |
RCAS1/EBAG9 Polyclonal Antibody, APC-Cy5 Conjugated |
IF(IHC-P), IF(IHC-F), IF(ICC) |
Mouse |
Human, Cow, Pig, Chicken, Rabbit |
Specifications |
APC-Cy5 |
Rabbit |
KLH conjugated synthetic peptide derived from human RCAS1 |
151-213/213 |
Polyclonal |
IgG |
1ug/ul |
Purified by Protein A. |
Aqueous buffered solution containing 0.01M TBS (pH7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol. |
Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles. |
Target |
9166 |
O00559 |
Cytoplasm, Cell membrane |
BAG9; Cancer associated surface antigen; Cancer associated surface antigen RCAS1; EB9; EBAG 9; Estrogen receptor binding fragment associated gene 9 protein; Estrogen receptor binding site associated antigen 9; PDAF; RCAS 1; RCAS1; Receptor binding cancer antigen expressed on SiSo cells. |
This gene was identified as an estrogen-responsive gene. Regulation of transcription by estrogen is mediated by estrogen receptor, which binds to the estrogen-responsive element found in the 5'-flanking region of this gene. The encoded protein is a tumor-associated antigen that is expressed at high frequency in a variety of cancers. This gene may also participate in the suppression of cell proliferation and inducing apoptotic cell death through activation of interleukin-1-beta converting enzyme (ICE)-like proteases. Alternate splicing results in multiple transcript variants. A pseudogene of this gene has been defined on chromosome 10. |
Application Dilution |
IF(IHC-P) |
1:50-200 |
IF(IHC-F) |
1:50-200 |
IF(ICC) |
1:50-200 |